Paloma Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Paloma Partners’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-378	Closed	-$91.9K	–	848
2024 Q2	$91.9K	Sell	378 -2,872	-88%	-$698K	﹤0.01%	671
2024 Q1	$486K	Buy	+3,250	New	+$486K	0.03%	212
2023 Q4	–	Sell	-64	Closed	-$11.3K	–	283
2023 Q3	$11.3K	Buy	+64	New	+$11.3K	﹤0.01%	183
2023 Q2	–	Sell	-531	Closed	-$106K	–	241
2023 Q1	$106K	Buy	+531	New	+$106K	﹤0.01%	174
2022 Q4	–	Sell	-1,101	Closed	-$220K	–	311
2022 Q3	$220K	Buy	+1,101	New	+$220K	0.01%	226
2021 Q4	–	Sell	-1,697	Closed	-$320K	–	1476
2021 Q3	$320K	Buy	+1,697	New	+$320K	0.01%	584
2020 Q4	–	Sell	-43,141	Closed	-$6.28M	–	1385
2020 Q3	$6.28M	Buy	+43,141	New	+$6.28M	0.16%	80
2020 Q1	–	Sell	-20,534	Closed	-$2.37M	–	1094
2019 Q4	$2.37M	Buy	+20,534	New	+$2.37M	0.04%	409
2018 Q4	–	Sell	-3,956	Closed	-$345K	–	985
2018 Q3	$345K	Sell	3,956 -6,429	-62%	-$561K	0.01%	896
2018 Q2	$1.02M	Buy	+10,385	New	+$1.02M	0.02%	500
2018 Q1	–	Sell	-2,335	Closed	-$297K	–	1391
2017 Q4	$297K	Sell	2,335 -11,588	-83%	-$1.47M	﹤0.01%	968
2017 Q3	$1.64M	Sell	13,923 -9,055	-39%	-$1.06M	0.02%	426
2017 Q2	$1.83M	Buy	22,978 +7,467	+48%	+$596K	0.02%	460
2017 Q1	$795K	Sell	15,511 -10,027	-39%	-$514K	0.01%	935
2016 Q4	$956K	Buy	+25,538	New	+$956K	0.01%	814
2016 Q1	–	Sell	-11,900	Closed	-$1.12M	–	1443
2015 Q4	$1.12M	Buy	11,900 +8,360	+236%	+$787K	0.03%	407
2015 Q3	$284K	Sell	3,540 -17,346	-83%	-$1.39M	0.01%	993
2015 Q2	$2.5M	Buy	20,886 +5,502	+36%	+$659K	0.05%	244
2015 Q1	$1.61M	Buy	+15,384	New	+$1.61M	0.05%	276
2014 Q4	–	Sell	-35,233	Closed	-$2.75M	–	1047
2014 Q3	$2.75M	Sell	35,233 -89,647	-72%	-$7M	0.13%	140
2014 Q2	$7.89M	Buy	124,880 +120,940	+3,070%	+$7.64M	0.32%	59
2014 Q1	$265K	Buy	+3,940	New	+$265K	0.02%	479
2013 Q4	–	Sell	-4,271	Closed	-$273K	–	977
2013 Q3	$273K	Buy	+4,271	New	+$273K	0.01%	668